vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and GCM Grosvenor Inc. (GCMG). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $177.1M, roughly 1.6× GCM Grosvenor Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 32.8%, a 63.5% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs 7.2%). Over the past eight quarters, GCM Grosvenor Inc.'s revenue compounded faster (27.5% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
GCM Grosvenor is an American alternative asset management firm, with approximately $76 billion in assets under management and approximately 530 professionals as of 2023.
ACAD vs GCMG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $177.1M |
| Net Profit | $273.6M | $58.2M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 30.9% |
| Net Margin | 96.3% | 32.8% |
| Revenue YoY | 9.4% | 7.2% |
| Net Profit YoY | 90.3% | 149.2% |
| EPS (diluted) | $1.61 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $177.1M | ||
| Q3 25 | $278.6M | $135.0M | ||
| Q2 25 | $264.6M | $119.7M | ||
| Q1 25 | $244.3M | $125.8M | ||
| Q4 24 | $259.6M | $165.3M | ||
| Q3 24 | $250.4M | $122.9M | ||
| Q2 24 | $242.0M | $117.0M | ||
| Q1 24 | $205.8M | $108.9M |
| Q4 25 | $273.6M | $58.2M | ||
| Q3 25 | $71.8M | $10.5M | ||
| Q2 25 | $26.7M | $15.4M | ||
| Q1 25 | $19.0M | $463.0K | ||
| Q4 24 | $143.7M | $7.6M | ||
| Q3 24 | $32.8M | $4.2M | ||
| Q2 24 | $33.4M | $4.8M | ||
| Q1 24 | $16.6M | $2.1M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — | ||
| Q1 24 | 88.8% | — |
| Q4 25 | 6.1% | 30.9% | ||
| Q3 25 | 12.8% | 32.7% | ||
| Q2 25 | 12.2% | 16.1% | ||
| Q1 25 | 7.9% | 12.2% | ||
| Q4 24 | 59.1% | 26.4% | ||
| Q3 24 | 12.6% | 20.3% | ||
| Q2 24 | 12.6% | 17.8% | ||
| Q1 24 | 7.4% | -14.7% |
| Q4 25 | 96.3% | 32.8% | ||
| Q3 25 | 25.8% | 7.8% | ||
| Q2 25 | 10.1% | 12.9% | ||
| Q1 25 | 7.8% | 0.4% | ||
| Q4 24 | 55.4% | 4.6% | ||
| Q3 24 | 13.1% | 3.4% | ||
| Q2 24 | 13.8% | 4.1% | ||
| Q1 24 | 8.0% | 2.0% |
| Q4 25 | $1.61 | $0.23 | ||
| Q3 25 | $0.42 | $0.16 | ||
| Q2 25 | $0.16 | $0.05 | ||
| Q1 25 | $0.11 | $-0.02 | ||
| Q4 24 | $0.86 | $0.09 | ||
| Q3 24 | $0.20 | $0.03 | ||
| Q2 24 | $0.20 | $0.04 | ||
| Q1 24 | $0.10 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $242.1M |
| Total DebtLower is stronger | — | $428.4M |
| Stockholders' EquityBook value | $1.2B | $27.0M |
| Total Assets | $1.6B | $813.8M |
| Debt / EquityLower = less leverage | — | 15.87× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $242.1M | ||
| Q3 25 | $258.0M | $182.7M | ||
| Q2 25 | $253.6M | $136.3M | ||
| Q1 25 | $217.7M | $94.5M | ||
| Q4 24 | $319.6M | $89.5M | ||
| Q3 24 | $155.1M | $98.4M | ||
| Q2 24 | $177.1M | $73.9M | ||
| Q1 24 | $204.7M | $41.9M |
| Q4 25 | — | $428.4M | ||
| Q3 25 | — | $429.3M | ||
| Q2 25 | — | $430.2M | ||
| Q1 25 | — | $431.1M | ||
| Q4 24 | — | $432.0M | ||
| Q3 24 | — | $432.9M | ||
| Q2 24 | — | $433.8M | ||
| Q1 24 | — | $384.0M |
| Q4 25 | $1.2B | $27.0M | ||
| Q3 25 | $917.3M | $-7.4M | ||
| Q2 25 | $822.4M | $-12.3M | ||
| Q1 25 | $765.2M | $-28.3M | ||
| Q4 24 | $732.8M | $-27.6M | ||
| Q3 24 | $577.2M | $-31.9M | ||
| Q2 24 | $516.7M | $-28.5M | ||
| Q1 24 | $464.0M | $-26.4M |
| Q4 25 | $1.6B | $813.8M | ||
| Q3 25 | $1.3B | $685.9M | ||
| Q2 25 | $1.2B | $636.9M | ||
| Q1 25 | $1.1B | $579.8M | ||
| Q4 24 | $1.2B | $612.7M | ||
| Q3 24 | $976.9M | $575.0M | ||
| Q2 24 | $914.1M | $543.9M | ||
| Q1 24 | $855.1M | $497.3M |
| Q4 25 | — | 15.87× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $183.5M |
| Free Cash FlowOCF − Capex | — | $175.0M |
| FCF MarginFCF / Revenue | — | 98.8% |
| Capex IntensityCapex / Revenue | — | 4.8% |
| Cash ConversionOCF / Net Profit | -0.18× | 3.16× |
| TTM Free Cash FlowTrailing 4 quarters | — | $326.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $183.5M | ||
| Q3 25 | $74.3M | $79.8M | ||
| Q2 25 | $64.0M | $42.0M | ||
| Q1 25 | $20.3M | $33.3M | ||
| Q4 24 | $40.4M | $148.8M | ||
| Q3 24 | $63.2M | $69.0M | ||
| Q2 24 | $25.0M | $17.5M | ||
| Q1 24 | $29.1M | $24.2M |
| Q4 25 | — | $175.0M | ||
| Q3 25 | $73.9M | $78.3M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | — | $32.1M | ||
| Q4 24 | — | $132.0M | ||
| Q3 24 | $63.2M | $62.2M | ||
| Q2 24 | — | $12.8M | ||
| Q1 24 | — | $20.0M |
| Q4 25 | — | 98.8% | ||
| Q3 25 | 26.5% | 58.0% | ||
| Q2 25 | — | 34.1% | ||
| Q1 25 | — | 25.5% | ||
| Q4 24 | — | 79.9% | ||
| Q3 24 | 25.2% | 50.6% | ||
| Q2 24 | — | 10.9% | ||
| Q1 24 | — | 18.4% |
| Q4 25 | — | 4.8% | ||
| Q3 25 | 0.1% | 1.1% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | 0.0% | 5.5% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 3.9% |
| Q4 25 | -0.18× | 3.16× | ||
| Q3 25 | 1.03× | 7.61× | ||
| Q2 25 | 2.40× | 2.72× | ||
| Q1 25 | 1.07× | 71.84× | ||
| Q4 24 | 0.28× | 19.54× | ||
| Q3 24 | 1.93× | 16.60× | ||
| Q2 24 | 0.75× | 3.64× | ||
| Q1 24 | 1.76× | 11.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
GCMG
| Asset Management1 | $108.6M | 61% |
| Management Service Incentive Performance Fees | $61.7M | 35% |
| Management Service Incentive Carried Interest | $5.1M | 3% |
| Service Other | $1.8M | 1% |
